Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Vertex’s post-test surge holds up as investors clamor to company
MarketWatch
Saturday, April 20, 2013 - 10:55am
tags:
Vertex Pharmaceuticals, VX-661, cystic fibrosis
BMY, Santaris Pharma Team Up
Yahoo/Zacks
Saturday, April 20, 2013 - 10:54am
tags:
Bristol-Myers Squibb, Santaris
Novo Nordisk Unveils New U.S. Headquarters
Yahoo
Friday, April 19, 2013 - 12:25pm
tags:
Novo Nordisk
Russia rejects Abbott Laboratories' plan to buy Petrovax
Reuters
Friday, April 19, 2013 - 12:16pm
tags:
Petrovax, M&A, Abbott Laboratories, Russia
Orphan Drug Biotechs Do It Best
Motley Fool
Friday, April 19, 2013 - 12:14pm
tags:
orphan drugs, Alexion, Biomarin, Vertex Pharmaceuticals
Report: Don't count Celltrion out of Rituxan biosim race
Fierce Biotech
Friday, April 19, 2013 - 12:08pm
tags:
Celltrion, biosimilars, Rituxan
Takeda in more trouble at home over recall of mislabeled vials
Fierce Pharma
Friday, April 19, 2013 - 12:07pm
tags:
Takeda, recalls
Bristol-Myers Squibb: Growing Bigger and Better
Motley Fool
Friday, April 19, 2013 - 12:05pm
tags:
Bristol-Myers Squibb
Vivus Seeing Traction With Qsymia
Seeking Alpha
Friday, April 19, 2013 - 11:53am
tags:
Qsymia, Vivus, Orexigen, Arena Pharmaceuticals, obesity
Intercept Pharmaceuticals: The Risks That No One Is Talking About
Seeking Alpha
Friday, April 19, 2013 - 11:47am
tags:
Intercept Pharma
GlaxoSmithKline Accused of Market Abuse
Motley Fool
Friday, April 19, 2013 - 11:46am
tags:
GSK, Seroxat, antidepressants
Big Biotech growth “outpacing Big Pharma”
Pharma Times, UK
Friday, April 19, 2013 - 9:12am
tags:
biotech, Big Pharma
Cubist Pharma 1Q income falls after acquisition
Yahoo/AP
Friday, April 19, 2013 - 8:54am
tags:
earnings, Cubist Pharma
Worth Repeating: Vertex Is The Next Gilead Sciences
TheStreet.com
Friday, April 19, 2013 - 8:54am
tags:
Gilead, Vertex Pharmaceuticals, Kalydeco, VX-661
Astellas, GSK vie to make 'high altitude' anemia pill
Reuters
Friday, April 19, 2013 - 8:52am
tags:
Astellas, GSK, anemia, GSK 1278863, FibroGen, FG-4592
Earnings Preview: Amgen reports 1Q results Tuesday
Yahoo/AP
Friday, April 19, 2013 - 8:50am
tags:
Amgen, earnings
Why Did Vanda Pharmaceuticals Hit A 52-Week High?
Seeking Alpha
Friday, April 19, 2013 - 8:49am
tags:
Vanda, Sanofi, Novartis, Eli Lilly, tasimelteon, Fanapt
Merck's Promising Vaccine Empire
Seeking Alpha
Friday, April 19, 2013 - 8:47am
tags:
vaccines, Merck, Gardasil, ProQuad, Varivax, Zostavax, Pneumovax
Epizyme hits the biotech IPO queue with rapid R&D plan for cancer drugs
Fierce Biotech
Thursday, April 18, 2013 - 7:01pm
tags:
Epizyme, IPOs, R&D, cancer
3 Biotechs Targeting Breast Cancer
Seeking Alpha
Thursday, April 18, 2013 - 6:59pm
tags:
breast cancer, Pfizer, Celldex, Galena Biopharma

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.